Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
Saved in:
| Title: | Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study. |
|---|---|
| Authors: | Verbeek MWC; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Buracchi C; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza (MB), Italy., Laqua A; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Sedek L; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Flores-Montero J; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Hofmans M; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., Sobral de Costa E; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Nováková M; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Mejstrikova E; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Barrena S; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Kohlscheen S; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Szczepanowski M; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Kulis J; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Oliveira E; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Jugooa R; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., de Jong AX; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Szczepanski T; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Philippé J; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., van Dongen JJM; Department of Immunohematology and Blood Transfusion (IHB), University Medical Center (LUMC), Leiden, the Netherlands., Orfao A; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Brüggemann M; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Gaipa G; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza (MB), Italy., van der Velden VHJ; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. |
| Source: | British journal of haematology [Br J Haematol] 2022 Apr; Vol. 197 (1), pp. 76-81. Date of Electronic Publication: 2021 Dec 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34881427 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Verbeek+MWC%22">Verbeek MWC</searchLink>; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Buracchi+C%22">Buracchi C</searchLink>; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza (MB), Italy.<br /><searchLink fieldCode="AU" term="%22Laqua+A%22">Laqua A</searchLink>; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Nierkens+S%22">Nierkens S</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sedek+L%22">Sedek L</searchLink>; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.<br /><searchLink fieldCode="AU" term="%22Flores-Montero+J%22">Flores-Montero J</searchLink>; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Hofmans+M%22">Hofmans M</searchLink>; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Sobral+de+Costa+E%22">Sobral de Costa E</searchLink>; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Nováková+M%22">Nováková M</searchLink>; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Mejstrikova+E%22">Mejstrikova E</searchLink>; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Barrena+S%22">Barrena S</searchLink>; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Kohlscheen+S%22">Kohlscheen S</searchLink>; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Szczepanowski+M%22">Szczepanowski M</searchLink>; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Kulis+J%22">Kulis J</searchLink>; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.<br /><searchLink fieldCode="AU" term="%22Oliveira+E%22">Oliveira E</searchLink>; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Jugooa+R%22">Jugooa R</searchLink>; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Jong+AX%22">de Jong AX</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Szczepanski+T%22">Szczepanski T</searchLink>; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.<br /><searchLink fieldCode="AU" term="%22Philippé+J%22">Philippé J</searchLink>; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22van+Dongen+JJM%22">van Dongen JJM</searchLink>; Department of Immunohematology and Blood Transfusion (IHB), University Medical Center (LUMC), Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Orfao+A%22">Orfao A</searchLink>; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Brüggemann+M%22">Brüggemann M</searchLink>; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Gaipa+G%22">Gaipa G</searchLink>; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza (MB), Italy.<br /><searchLink fieldCode="AU" term="%22van+der+Velden+VHJ%22">van der Velden VHJ</searchLink>; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2022 Apr; Vol. 197 (1), pp. 76-81. <i>Date of Electronic Publication: </i>2021 Dec 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34881427 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.17992 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 76 Titles: – TitleFull: Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Verbeek MWC – PersonEntity: Name: NameFull: Buracchi C – PersonEntity: Name: NameFull: Laqua A – PersonEntity: Name: NameFull: Nierkens S – PersonEntity: Name: NameFull: Sedek L – PersonEntity: Name: NameFull: Flores-Montero J – PersonEntity: Name: NameFull: Hofmans M – PersonEntity: Name: NameFull: Sobral de Costa E – PersonEntity: Name: NameFull: Nováková M – PersonEntity: Name: NameFull: Mejstrikova E – PersonEntity: Name: NameFull: Barrena S – PersonEntity: Name: NameFull: Kohlscheen S – PersonEntity: Name: NameFull: Szczepanowski M – PersonEntity: Name: NameFull: Kulis J – PersonEntity: Name: NameFull: Oliveira E – PersonEntity: Name: NameFull: Jugooa R – PersonEntity: Name: NameFull: de Jong AX – PersonEntity: Name: NameFull: Szczepanski T – PersonEntity: Name: NameFull: Philippé J – PersonEntity: Name: NameFull: van Dongen JJM – PersonEntity: Name: NameFull: Orfao A – PersonEntity: Name: NameFull: Brüggemann M – PersonEntity: Name: NameFull: Gaipa G – PersonEntity: Name: NameFull: van der Velden VHJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2022 Apr Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 197 – Type: issue Value: 1 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |
